Back to UBS Group AG UBS Group AG

CBIOCBIO
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in CRESCENT BIOPHARMA INC.

UBS Group AG holds 175,182 shares of CBIO (CRESCENT BIOPHARMA INC.), worth $3.2M as of 2026-Q2. The position was increased (+111.8% shares). CBIO represents 0.0% of UBS Group AG's portfolio.

Current Value

$3.2M

Current Shares

175,182

Total Value Change

+$3.1M

Total Shares Change

+174,959

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
175,182
+111.8%
$3.2M0.0%$18.00
43
2026-Q1
Increased
82,706
+1060.8%
$1.5M0.0%$11.19
41
2025-Q4
Decreased
7,125
-43.7%
$84,5030.0%$11.60
0
2025-Q3
Increased
12,661
+5577.6%
$150,5390.0%$12.29
25
2025-Q2
New
223
-
$3,5990.0%$15.90
21

Other major holders of CBIO: FMR LLC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used